Latest Headlines

  1. Abbott’s Sensor-Enabled Ablation Catheter Gains CE Mark Approval

    Abbott (NYSE: ABT) today announced CE Mark of the TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™, developed to make it easier for physicians to more effectively treat atrial fibrillation (AF), a condition in which the upper chambers of the heart beat too fast.

  2. Cardiff Intl. To Acquire Prostate Dx Device Maker MedicaMetrix

    Cardiff International, Inc. (OTCQB: CDIF) and MedicaMetrix®, Inc. (Private; "MedicaMetrix") announced today they have signed a Letter of Intent agreement under which MedicaMetrix will merge into Cardiff International as its subsidiary, MedicaMetrix, Inc., in an all-stock transaction valued at approximately $6 million. 

  3. Outsourced Pharma Announces San Diego Forum Agenda Following Successful Boston Event

    Outsourced Pharma announced the agenda for its San Diego event at the conclusion of its Boston conference held this past April. An Early Start on Drug Development and Manufacturing Outsourcing is scheduled for August 22-23 at the Hyatt Regency La Jolla. The complete agenda and list of panelists can be found here.

  4. Medrobotics’ Surgical Robot For Colorectal Procedures Gains FDA Clearance

    Medrobotics Corp., a medical robotics company, announced recently it has received FDA regulatory clearance to market the Flex Robotic System for colorectal procedures in the United States.

  5. Abbott Wins CE Mark For First Smartphone-Compatible Insertable Cardiac Monitor

    Abbott (NYSE: ABT) today announced CE Mark and first use of the new Confirm Rx™ Insertable Cardiac Monitor (ICM), the world's first smartphone compatible ICM that will help physicians identify difficult to detect cardiac arrhythmias, including atrial fibrillation (AF), to help guide therapy.

  6. Systemic Therapy Outperforms Intraocular Implant For Treating Uveitis

    Systemic therapy consisting of corticosteroids and immunosuppressants preserved vision of uveitis patients better — and had fewer adverse outcomes — than a long-lasting corticosteroid intraocular implant, according to a clinical trial funded by the National Eye Institute (NEI).

  7. LivaNova Touts Perceval Sutureless Valve Study Data

    LivaNova, PLC (“LivaNova” or the “Company”), a market-leading medical technology and innovation company, announced the presentation of data from multiple studies demonstrating the safety and the effectiveness of the Perceval sutureless valve for Aortic Valve Replacement (AVR) patients and the Memo 3D ReChord for mitral valve repair.

  8. FDA Clears First Flexible Shaver Technology For Interventional Gastroenterology

    Interscope, Inc. announced recently the receipt of marketing clearance from the FDA for the EndoRotor System in the USA to commercialize in gastroenterology and colorectal surgery.

  9. Medical Device Companies Cope With India's Stent Price Caps

    Medical device companies Abbott, Boston Scientific, Johnson & Johnson, and Medtronic are trying to come to grips with Indian regulators’ decision to set a price cap on cardiac stents by refiling applications to withdraw certain products, as well as lobbying against such regulation, which they contend increases the risk of introducing new products into the country and places such products out of patients’ reach.

  10. Hill-Rom Unveils Mobile, Connected Airway Clearance System For Patients On the Move

    Hill-Rom has unveiled an airway clearance system that is integrated into a mobile vest and allows patients more freedom of movement while receiving their respiratory therapies.